Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.

Transforming growth factor beta 1 (TGF beta 1)-null mice die fro complications due to an early-onset multifocal inflammatory disorder. We show here that cardiac cells are hyperproliferative and that intercellular adhesion molecule 1 (ICAM-1) is elevated. To determine which phenotypes are primarily caused by a deficiency in TGF beta 1 from those that are secondary to inflammation, we applied immunosuppressive therapy and genetic combination with the severe combined immunodeficiency (SCID) mutation to inhibit the inflammatory response. Treatment with antibodies to the leukocyte function-associated antigen 1 doubled longevity, reduced inflammation, and delayed heart cell proliferation. TGF beta 1-null SCID mice displayed no inflammation or cardiac cell proliferation, survived to adulthood, and exhibited normal major histocompatibility complex II (MHC II) and ICAM-1 levels. TGF beta 1-null pups born to a TGF beta 1-null SCID mother presented no gross congenital heart defects, indicating that TGF beta 1 alone does not play an essential role in heart development. These results indicate that lymphocytes are essential for the inflammatory response, cardiac cell proliferation, and elevated MHC II and ICAM-1 expression, revealing a vital role for TGF beta 1 in regulating lymphocyte proliferation and activation, which contribute to the maintenance of self tolerance.

[1]  V. Baichwal,et al.  Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Kulkarni,et al.  Immune dysregulation in TGF-beta 1-deficient mice. , 1994, Journal of immunology.

[3]  M. Sporn,et al.  Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.

[4]  A. Kulkarni,et al.  Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Wahl,et al.  Transforming growth factor β: a matter of life and death , 1994 .

[6]  M. Sporn,et al.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[9]  Y. Ogawa,et al.  Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. , 1992, Experimental hematology.

[10]  F. Ruscetti,et al.  Transforming growth factor-beta1 in heart development , 1992, Mechanisms of Development.

[11]  K. Roth,et al.  Temporal differentiation and migration of substance P, serotonin, and secretin immunoreactive enteroendocrine cells in the mouse proximal small intestine , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[12]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[13]  S. Breit,et al.  Interaction of Immune and Connective Tissue Cells: I. The Effect of Lymphokines and Monokines on Fibroblast Growth , 1990, Journal of leukocyte biology.

[14]  G. Wong,et al.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. , 1988, Journal of immunology.

[15]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[16]  G. Boivin,et al.  Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. , 1995, The American journal of pathology.

[17]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[18]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.